Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

Objective: Long-term survivors (LS) of non-small cell lung cancer (NSCLC) without driver alterations, displaying an overall survival (OS) of more than 3 years, comprise around 10% of cases in several series treated with chemotherapy. There are classical prognosis factors for these cases [stage, East...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Rubio, Juan, Ponce, Santiago, Álvarez, Rosa, Olmedo, María Eugenia, Falagan, Sandra, Mielgo, Xabier, Navarro, Fátima, Cruz, Patricia, Cabezón-Gutiérrez, Luis, Aguado, Carlos, Colmenarejo, Gonzalo, Muñoz-Fernández de Leglaria, Marta, Enguita, Ana Belén, Cebollero, María, Benito, Amparo, Alemany, Isabel, del Castillo, Carolina, Ramos, Ricardo, Ramírez de Molina, Ana, Casado, Enrique, Sereno, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309469/
https://www.ncbi.nlm.nih.gov/pubmed/32587780
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309469/
https://www.ncbi.nlm.nih.gov/pubmed/32587780
http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0363

Ejemplares similares